

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.92191157 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.38069430 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.65684024 |
| 4 | viral transcription (GO:0019083) | 4.65286430 |
| 5 | translational termination (GO:0006415) | 4.54715836 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52499948 |
| 7 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.50539606 |
| 8 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.35761336 |
| 9 | translational elongation (GO:0006414) | 4.33340781 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.32823564 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.29581118 |
| 12 | DNA strand elongation (GO:0022616) | 4.25787853 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.20751712 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.07202335 |
| 15 | nucleobase biosynthetic process (GO:0046112) | 3.97612302 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95540510 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.95540510 |
| 18 | DNA replication initiation (GO:0006270) | 3.93806923 |
| 19 | protein targeting to ER (GO:0045047) | 3.93408021 |
| 20 | cotranslational protein targeting to membrane (GO:0006613) | 3.93165320 |
| 21 | translational initiation (GO:0006413) | 3.90557955 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 3.83861258 |
| 23 | telomere maintenance via recombination (GO:0000722) | 3.80927202 |
| 24 | purine nucleobase biosynthetic process (GO:0009113) | 3.79612648 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 3.77484818 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.76687349 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76489007 |
| 28 | protein localization to endoplasmic reticulum (GO:0070972) | 3.74991118 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.71878968 |
| 30 | proteasome assembly (GO:0043248) | 3.71464708 |
| 31 | ribosome biogenesis (GO:0042254) | 3.70375367 |
| 32 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.70159350 |
| 33 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.68245829 |
| 34 | viral life cycle (GO:0019058) | 3.66154198 |
| 35 | DNA unwinding involved in DNA replication (GO:0006268) | 3.60974747 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.60193254 |
| 37 | pseudouridine synthesis (GO:0001522) | 3.54446530 |
| 38 | cellular protein complex disassembly (GO:0043624) | 3.53835158 |
| 39 | telomere maintenance via telomere lengthening (GO:0010833) | 3.52105840 |
| 40 | ribosome assembly (GO:0042255) | 3.47983355 |
| 41 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.43875973 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.43875973 |
| 43 | mitotic recombination (GO:0006312) | 3.42981376 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42714421 |
| 45 | rRNA processing (GO:0006364) | 3.36141240 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32202783 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31886781 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30746406 |
| 49 | translation (GO:0006412) | 3.30483637 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 3.26436449 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.26163248 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.26163248 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.26163248 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.26163248 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 3.26163248 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.26163248 |
| 57 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.24922935 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.24764475 |
| 59 | response to interleukin-15 (GO:0070672) | 3.24248541 |
| 60 | DNA replication checkpoint (GO:0000076) | 3.23837063 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 3.22987802 |
| 62 | rRNA metabolic process (GO:0016072) | 3.22338087 |
| 63 | IMP biosynthetic process (GO:0006188) | 3.20321789 |
| 64 | regulation of gamma-delta T cell activation (GO:0046643) | 3.18246639 |
| 65 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.17219221 |
| 66 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.17219221 |
| 67 | spliceosomal snRNP assembly (GO:0000387) | 3.15661040 |
| 68 | protein complex disassembly (GO:0043241) | 3.14986095 |
| 69 | neutrophil activation (GO:0042119) | 3.14302091 |
| 70 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.12157598 |
| 71 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11483989 |
| 72 | mitotic nuclear envelope disassembly (GO:0007077) | 3.10366389 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.10336778 |
| 74 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.10177185 |
| 75 | T cell migration (GO:0072678) | 3.10128098 |
| 76 | rRNA modification (GO:0000154) | 3.09394877 |
| 77 | negative regulation of RNA splicing (GO:0033119) | 3.09179284 |
| 78 | negative regulation of B cell proliferation (GO:0030889) | 3.09171144 |
| 79 | regulation of regulatory T cell differentiation (GO:0045589) | 3.08811539 |
| 80 | mitotic metaphase plate congression (GO:0007080) | 3.05497869 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 3.05094690 |
| 82 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.05094690 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05034653 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04847833 |
| 85 | IMP metabolic process (GO:0046040) | 3.04817214 |
| 86 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.04224561 |
| 87 | cellular response to interleukin-15 (GO:0071350) | 3.04150822 |
| 88 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.04124989 |
| 89 | cellular component biogenesis (GO:0044085) | 3.02200467 |
| 90 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01974089 |
| 91 | histone mRNA catabolic process (GO:0071044) | 3.01691251 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.00708285 |
| 93 | macromolecular complex disassembly (GO:0032984) | 3.00598375 |
| 94 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.00485844 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99962484 |
| 96 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.98308278 |
| 97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.98308278 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.98240034 |
| 99 | negative regulation of ligase activity (GO:0051352) | 2.98240034 |
| 100 | respiratory burst (GO:0045730) | 2.96101974 |
| 101 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.94552656 |
| 102 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.94552656 |
| 103 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.94552656 |
| 104 | mRNA catabolic process (GO:0006402) | 2.93049404 |
| 105 | positive T cell selection (GO:0043368) | 2.92847481 |
| 106 | CENP-A containing nucleosome assembly (GO:0034080) | 2.92195592 |
| 107 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.91988492 |
| 108 | nuclear envelope disassembly (GO:0051081) | 2.90657155 |
| 109 | membrane disassembly (GO:0030397) | 2.90657155 |
| 110 | maturation of 5.8S rRNA (GO:0000460) | 2.89964796 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89036847 |
| 112 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88972192 |
| 113 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.88972192 |
| 114 | regulation of protein heterodimerization activity (GO:0043497) | 2.87611744 |
| 115 | granulocyte activation (GO:0036230) | 2.87519839 |
| 116 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87434720 |
| 117 | detection of other organism (GO:0098543) | 2.87238174 |
| 118 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.86717049 |
| 119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86362136 |
| 120 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.86013101 |
| 121 | cell cycle G1/S phase transition (GO:0044843) | 2.86013101 |
| 122 | chromatin remodeling at centromere (GO:0031055) | 2.85798880 |
| 123 | RNA catabolic process (GO:0006401) | 2.85753020 |
| 124 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85580873 |
| 125 | histone-serine phosphorylation (GO:0035404) | 2.85422364 |
| 126 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.84212221 |
| 127 | protein localization to kinetochore (GO:0034501) | 2.83830852 |
| 128 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.83014584 |
| 129 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.83013123 |
| 130 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.82814182 |
| 131 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.82814182 |
| 132 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80921516 |
| 133 | immunoglobulin mediated immune response (GO:0016064) | 2.80683773 |
| 134 | B cell mediated immunity (GO:0019724) | 2.80364747 |
| 135 | metaphase plate congression (GO:0051310) | 2.79315232 |
| 136 | negative T cell selection (GO:0043383) | 2.78734277 |
| 137 | establishment of integrated proviral latency (GO:0075713) | 2.76975039 |
| 138 | viral mRNA export from host cell nucleus (GO:0046784) | 2.75826425 |
| 139 | protein deneddylation (GO:0000338) | 2.75321985 |
| 140 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.74699474 |
| 141 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.74699474 |
| 142 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73928408 |
| 143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73715186 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.72203412 |
| 145 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71984219 |
| 146 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.71900580 |
| 147 | neural tube formation (GO:0001841) | 2.70043183 |
| 148 | T cell homeostasis (GO:0043029) | 2.69023485 |
| 149 | detection of bacterium (GO:0016045) | 2.68917439 |
| 150 | histone mRNA metabolic process (GO:0008334) | 2.67133077 |
| 151 | cellular extravasation (GO:0045123) | 2.66326383 |
| 152 | negative thymic T cell selection (GO:0045060) | 2.66323938 |
| 153 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.63849868 |
| 154 | DNA demethylation (GO:0080111) | 2.62404891 |
| 155 | negative regulation of T cell mediated immunity (GO:0002710) | 2.60321486 |
| 156 | defense response to protozoan (GO:0042832) | 2.60086377 |
| 157 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59773916 |
| 158 | response to peptidoglycan (GO:0032494) | 2.59686037 |
| 159 | neutrophil mediated immunity (GO:0002446) | 2.58598254 |
| 160 | positive regulation of B cell differentiation (GO:0045579) | 2.57638055 |
| 161 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57220888 |
| 162 | regulation of translation in response to stress (GO:0043555) | 2.54616425 |
| 163 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54457418 |
| 164 | myeloid cell activation involved in immune response (GO:0002275) | 2.54070256 |
| 165 | leukocyte aggregation (GO:0070486) | 2.53963246 |
| 166 | transcription from mitochondrial promoter (GO:0006390) | 2.53055083 |
| 167 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.52875003 |
| 168 | positive regulation of protein homooligomerization (GO:0032464) | 2.51344650 |
| 169 | regulation of germinal center formation (GO:0002634) | 2.51308592 |
| 170 | negative regulation of adaptive immune response (GO:0002820) | 2.50033540 |
| 171 | microglial cell activation (GO:0001774) | 2.48713071 |
| 172 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.47765599 |
| 173 | T cell selection (GO:0045058) | 2.45420426 |
| 174 | dendritic cell migration (GO:0036336) | 2.44980696 |
| 175 | mast cell activation (GO:0045576) | 2.44803845 |
| 176 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.44797178 |
| 177 | positive regulation of interleukin-2 production (GO:0032743) | 2.44319170 |
| 178 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44192127 |
| 179 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.44079039 |
| 180 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43191768 |
| 181 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41311744 |
| 182 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.41297373 |
| 183 | interferon-gamma production (GO:0032609) | 2.40539430 |
| 184 | positive regulation of interferon-alpha production (GO:0032727) | 2.39642070 |
| 185 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.39342159 |
| 186 | detection of external biotic stimulus (GO:0098581) | 2.38519711 |
| 187 | B cell homeostasis (GO:0001782) | 2.38175624 |
| 188 | leukocyte degranulation (GO:0043299) | 2.35718186 |
| 189 | dendritic cell chemotaxis (GO:0002407) | 2.35343318 |
| 190 | macrophage activation involved in immune response (GO:0002281) | 2.34952075 |
| 191 | negative regulation of B cell activation (GO:0050869) | 2.34905168 |
| 192 | regulation of interferon-alpha production (GO:0032647) | 2.33755376 |
| 193 | histamine secretion (GO:0001821) | 2.33299182 |
| 194 | lymphocyte homeostasis (GO:0002260) | 2.33291974 |
| 195 | regulation of B cell proliferation (GO:0030888) | 2.33108051 |
| 196 | response to host immune response (GO:0052572) | 2.32836517 |
| 197 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32836517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.62433299 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.33046818 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.24968230 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.86792372 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.01607350 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96114558 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94933202 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.92609637 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.92574793 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88666844 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87999558 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.79673236 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76142852 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.70881209 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65618312 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.65468852 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44154116 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44008670 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.43739171 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32186398 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31259731 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.30309249 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29777872 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29204864 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.26164137 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.18347140 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13014873 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.08037415 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04875756 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03711421 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.01553773 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97387723 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96669664 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94133688 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93333140 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88091108 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.87642959 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.83269927 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82847514 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81741600 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80594924 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75849484 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75662842 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.69056116 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68739672 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68601554 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.67734820 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.64926859 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63823254 |
| 50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63104539 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62781092 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61301482 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60890961 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60546886 |
| 55 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60332418 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57514729 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56212637 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55151397 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54957155 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53727506 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53305143 |
| 62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52087795 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51440162 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50885857 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50619147 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.49804085 |
| 67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48794028 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47078764 |
| 69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45014958 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.43283347 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43100605 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41230046 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38323531 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35878754 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33905493 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.33553055 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32488194 |
| 78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31871746 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31645437 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29459565 |
| 81 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29235553 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28484908 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28354839 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27498432 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26066879 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22688008 |
| 87 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20840032 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20212026 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19530900 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19315629 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18827766 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18518127 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18051290 |
| 94 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.17696360 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16347361 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15928592 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15788334 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15718196 |
| 99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14479238 |
| 100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11961947 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09942266 |
| 102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09806445 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08957305 |
| 104 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07373645 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04907737 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04497022 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03160507 |
| 108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02022228 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01799751 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99013353 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97360058 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96424415 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96244114 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94982681 |
| 115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94742645 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94722344 |
| 117 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94288977 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94131816 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 0.93920605 |
| 120 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93731734 |
| 121 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93320973 |
| 122 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92455444 |
| 123 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90554503 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.89977935 |
| 125 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89956987 |
| 126 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89395227 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89285220 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 0.88053443 |
| 129 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88035201 |
| 130 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86999445 |
| 131 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.86871000 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 0.86857827 |
| 133 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86265699 |
| 134 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85823074 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81651687 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80531021 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.78612806 |
| 138 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78526857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.92411841 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.10775072 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.70744271 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.39437293 |
| 5 | MP0003077_abnormal_cell_cycle | 3.29295328 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.24909377 |
| 7 | MP0003724_increased_susceptibility_to | 3.20428612 |
| 8 | MP0008058_abnormal_DNA_repair | 2.73615300 |
| 9 | MP0003787_abnormal_imprinting | 2.53994909 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.52257740 |
| 11 | MP0000490_abnormal_crypts_of | 2.29874215 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.28202553 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.21684296 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.20645048 |
| 15 | MP0008057_abnormal_DNA_replication | 2.19110330 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.15552766 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 2.13591439 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.01776081 |
| 19 | MP0002398_abnormal_bone_marrow | 2.01197543 |
| 20 | MP0008932_abnormal_embryonic_tissue | 1.97708988 |
| 21 | MP0006054_spinal_hemorrhage | 1.95983352 |
| 22 | MP0005671_abnormal_response_to | 1.94089760 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.93027878 |
| 24 | MP0000685_abnormal_immune_system | 1.90410565 |
| 25 | MP0002722_abnormal_immune_system | 1.86339955 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.85414057 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.84817338 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.84817338 |
| 29 | MP0009785_altered_susceptibility_to | 1.81470188 |
| 30 | MP0000350_abnormal_cell_proliferation | 1.77313392 |
| 31 | MP0001730_embryonic_growth_arrest | 1.72301254 |
| 32 | MP0004147_increased_porphyrin_level | 1.72039312 |
| 33 | MP0003786_premature_aging | 1.71763721 |
| 34 | MP0002019_abnormal_tumor_incidence | 1.66719388 |
| 35 | MP0003303_peritoneal_inflammation | 1.65928606 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.63768567 |
| 37 | MP0010307_abnormal_tumor_latency | 1.63305871 |
| 38 | MP0006082_CNS_inflammation | 1.59420223 |
| 39 | MP0000313_abnormal_cell_death | 1.58511350 |
| 40 | MP0001800_abnormal_humoral_immune | 1.58420542 |
| 41 | MP0002429_abnormal_blood_cell | 1.57070433 |
| 42 | MP0009764_decreased_sensitivity_to | 1.55134886 |
| 43 | MP0000716_abnormal_immune_system | 1.52909500 |
| 44 | MP0009697_abnormal_copulation | 1.51236794 |
| 45 | MP0003186_abnormal_redox_activity | 1.50654930 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.49778073 |
| 47 | MP0001853_heart_inflammation | 1.49246322 |
| 48 | MP0001819_abnormal_immune_cell | 1.47222927 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.46123630 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.43767800 |
| 51 | MP0002723_abnormal_immune_serum | 1.43532451 |
| 52 | MP0003123_paternal_imprinting | 1.42090062 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.41388026 |
| 54 | MP0008260_abnormal_autophagy | 1.41020130 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.40590577 |
| 56 | MP0005025_abnormal_response_to | 1.40292386 |
| 57 | MP0008995_early_reproductive_senescence | 1.36768356 |
| 58 | MP0002080_prenatal_lethality | 1.36614350 |
| 59 | MP0000858_altered_metastatic_potential | 1.35710551 |
| 60 | MP0002928_abnormal_bile_duct | 1.35068922 |
| 61 | MP0000358_abnormal_cell_content/ | 1.34718024 |
| 62 | MP0001188_hyperpigmentation | 1.33815590 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.33256325 |
| 64 | MP0005310_abnormal_salivary_gland | 1.32770368 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.31129974 |
| 66 | MP0002009_preneoplasia | 1.31084960 |
| 67 | MP0001697_abnormal_embryo_size | 1.30262807 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.24661476 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 1.23018951 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.22058721 |
| 71 | MP0002405_respiratory_system_inflammati | 1.21850970 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.20137048 |
| 73 | MP0004381_abnormal_hair_follicle | 1.19620412 |
| 74 | MP0003121_genomic_imprinting | 1.15031062 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.14534132 |
| 76 | MP0002132_abnormal_respiratory_system | 1.14135233 |
| 77 | MP0003866_abnormal_defecation | 1.13491873 |
| 78 | MP0003436_decreased_susceptibility_to | 1.06863032 |
| 79 | MP0002006_tumorigenesis | 1.06510906 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.06229329 |
| 81 | MP0005380_embryogenesis_phenotype | 1.04129331 |
| 82 | MP0001672_abnormal_embryogenesis/_devel | 1.04129331 |
| 83 | MP0001873_stomach_inflammation | 1.03479425 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.01713000 |
| 85 | MP0001529_abnormal_vocalization | 0.99051754 |
| 86 | MP0003984_embryonic_growth_retardation | 0.98820697 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.98543743 |
| 88 | MP0001845_abnormal_inflammatory_respons | 0.97358908 |
| 89 | MP0004947_skin_inflammation | 0.97255855 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.96515551 |
| 91 | MP0002088_abnormal_embryonic_growth/wei | 0.94759689 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.94153017 |
| 93 | MP0002086_abnormal_extraembryonic_tissu | 0.94002996 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92785490 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.92248697 |
| 96 | MP0001790_abnormal_immune_system | 0.91759717 |
| 97 | MP0005387_immune_system_phenotype | 0.91759717 |
| 98 | MP0005023_abnormal_wound_healing | 0.90003380 |
| 99 | MP0008469_abnormal_protein_level | 0.89743389 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.87466206 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87127760 |
| 102 | MP0004883_abnormal_blood_vessel | 0.87057229 |
| 103 | MP0002419_abnormal_innate_immunity | 0.85933923 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.85113229 |
| 105 | MP0003718_maternal_effect | 0.83685003 |
| 106 | MP0001533_abnormal_skeleton_physiology | 0.82951701 |
| 107 | MP0002085_abnormal_embryonic_tissue | 0.82438694 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.81839754 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.80735892 |
| 110 | MP0000598_abnormal_liver_morphology | 0.79255077 |
| 111 | MP0002210_abnormal_sex_determination | 0.79226286 |
| 112 | MP0001764_abnormal_homeostasis | 0.77747112 |
| 113 | MP0001929_abnormal_gametogenesis | 0.76582509 |
| 114 | MP0001145_abnormal_male_reproductive | 0.75485205 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.74759818 |
| 116 | MP0005384_cellular_phenotype | 0.74605460 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.72847700 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.72263926 |
| 119 | MP0004484_altered_response_of | 0.72213874 |
| 120 | MP0002822_catalepsy | 0.71913859 |
| 121 | MP0000516_abnormal_urinary_system | 0.71359951 |
| 122 | MP0005367_renal/urinary_system_phenotyp | 0.71359951 |
| 123 | MP0001119_abnormal_female_reproductive | 0.70648815 |
| 124 | MP0003943_abnormal_hepatobiliary_system | 0.70564240 |
| 125 | MP0008873_increased_physiological_sensi | 0.70462675 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.70242771 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.69965995 |
| 128 | MP0002084_abnormal_developmental_patter | 0.69318790 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.69079736 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.68823867 |
| 131 | MP0005266_abnormal_metabolism | 0.68072190 |
| 132 | MP0008872_abnormal_physiological_respon | 0.67634149 |
| 133 | MP0002653_abnormal_ependyma_morphology | 0.67468012 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.67427329 |
| 135 | MP0001191_abnormal_skin_condition | 0.66958741 |
| 136 | MP0009763_increased_sensitivity_to | 0.66785330 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.66739101 |
| 138 | MP0003448_altered_tumor_morphology | 0.66038764 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.64116260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 6.00954471 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.86390661 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 4.33224217 |
| 4 | Stomatitis (HP:0010280) | 4.30083805 |
| 5 | Aplastic anemia (HP:0001915) | 4.26390913 |
| 6 | Reticulocytopenia (HP:0001896) | 4.02619840 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 3.83485457 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.70553935 |
| 9 | Thrombocytosis (HP:0001894) | 3.59147248 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.47336782 |
| 11 | Colon cancer (HP:0003003) | 3.46099649 |
| 12 | Pallor (HP:0000980) | 3.36836457 |
| 13 | Oral leukoplakia (HP:0002745) | 3.34025712 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.31250531 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.30649066 |
| 16 | IgM deficiency (HP:0002850) | 3.29956198 |
| 17 | Optic neuritis (HP:0100653) | 3.23093157 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.23093157 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.22664185 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.22664185 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 3.22110846 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 3.22110846 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 3.21628125 |
| 24 | Encephalitis (HP:0002383) | 3.14333076 |
| 25 | Microretrognathia (HP:0000308) | 3.13962310 |
| 26 | Type I transferrin isoform profile (HP:0003642) | 3.12431658 |
| 27 | Selective tooth agenesis (HP:0001592) | 3.08011713 |
| 28 | Meningitis (HP:0001287) | 3.00598056 |
| 29 | Microvesicular hepatic steatosis (HP:0001414) | 2.98863717 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 2.96924548 |
| 31 | Progressive muscle weakness (HP:0003323) | 2.90156979 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.89292718 |
| 33 | Macrocytic anemia (HP:0001972) | 2.84946337 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.77196245 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74181028 |
| 36 | Multiple enchondromatosis (HP:0005701) | 2.73972904 |
| 37 | Abnormality of DNA repair (HP:0003254) | 2.73022251 |
| 38 | Orchitis (HP:0100796) | 2.72774494 |
| 39 | Acute hepatic failure (HP:0006554) | 2.71775487 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71744248 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71744248 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.71232267 |
| 43 | Increased serum lactate (HP:0002151) | 2.69299925 |
| 44 | Vasculitis (HP:0002633) | 2.69231386 |
| 45 | Muscle fiber atrophy (HP:0100295) | 2.66207234 |
| 46 | Type 2 muscle fiber atrophy (HP:0003554) | 2.65754167 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.62427688 |
| 48 | Agnosia (HP:0010524) | 2.62005937 |
| 49 | Self-mutilation (HP:0000742) | 2.59638786 |
| 50 | B lymphocytopenia (HP:0010976) | 2.54234556 |
| 51 | Hepatic necrosis (HP:0002605) | 2.52461427 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.51069103 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.50145794 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.49758995 |
| 55 | Recurrent skin infections (HP:0001581) | 2.49271448 |
| 56 | Rough bone trabeculation (HP:0100670) | 2.48667782 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.48078593 |
| 58 | Thyroiditis (HP:0100646) | 2.47553676 |
| 59 | Combined immunodeficiency (HP:0005387) | 2.46693922 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.44993780 |
| 61 | Petechiae (HP:0000967) | 2.44842656 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.43016791 |
| 63 | Abnormality of T cells (HP:0002843) | 2.42339455 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.41932459 |
| 65 | Overlapping toe (HP:0001845) | 2.36500837 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.36165009 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.36165009 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36165009 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36165009 |
| 70 | Recurrent viral infections (HP:0004429) | 2.35802047 |
| 71 | Stomach cancer (HP:0012126) | 2.34143101 |
| 72 | Basal cell carcinoma (HP:0002671) | 2.32907886 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.31494154 |
| 74 | Nausea (HP:0002018) | 2.31219847 |
| 75 | Myelodysplasia (HP:0002863) | 2.30619267 |
| 76 | Breast hypoplasia (HP:0003187) | 2.29808697 |
| 77 | Pancreatic cysts (HP:0001737) | 2.27881693 |
| 78 | Hypoplasia of the pons (HP:0012110) | 2.27074478 |
| 79 | Sparse eyelashes (HP:0000653) | 2.26998193 |
| 80 | Premature graying of hair (HP:0002216) | 2.26862147 |
| 81 | Poor head control (HP:0002421) | 2.26772032 |
| 82 | Pancytopenia (HP:0001876) | 2.26730279 |
| 83 | Amaurosis fugax (HP:0100576) | 2.26550410 |
| 84 | Myositis (HP:0100614) | 2.26026103 |
| 85 | Leukocytosis (HP:0001974) | 2.24986010 |
| 86 | Chest pain (HP:0100749) | 2.22783860 |
| 87 | 11 pairs of ribs (HP:0000878) | 2.22716204 |
| 88 | Alveolar cell carcinoma (HP:0006519) | 2.21138484 |
| 89 | Poikiloderma (HP:0001029) | 2.18446761 |
| 90 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17959604 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.17805567 |
| 92 | Increased serum ferritin (HP:0003281) | 2.17384417 |
| 93 | Cellular immunodeficiency (HP:0005374) | 2.16601708 |
| 94 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.16114116 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 2.15653321 |
| 96 | IgG deficiency (HP:0004315) | 2.15221157 |
| 97 | Trismus (HP:0000211) | 2.11612016 |
| 98 | Urticaria (HP:0001025) | 2.10187883 |
| 99 | Lymphoma (HP:0002665) | 2.09871941 |
| 100 | Medulloblastoma (HP:0002885) | 2.08871457 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.08009852 |
| 102 | Recurrent sinusitis (HP:0011108) | 2.06903990 |
| 103 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.05636721 |
| 104 | Ependymoma (HP:0002888) | 2.05585721 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05485470 |
| 106 | Absent thumb (HP:0009777) | 2.04547352 |
| 107 | Pulmonary fibrosis (HP:0002206) | 2.02345475 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 2.02337559 |
| 109 | Type II lissencephaly (HP:0007260) | 2.01484970 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.00457490 |
| 111 | Slender long bone (HP:0003100) | 1.98376207 |
| 112 | Abnormality of the prostate (HP:0008775) | 1.98251893 |
| 113 | Increased CSF lactate (HP:0002490) | 1.98247470 |
| 114 | Retinal dysplasia (HP:0007973) | 1.98218252 |
| 115 | Keratitis (HP:0000491) | 1.97318111 |
| 116 | Obstructive lung disease (HP:0006536) | 1.96943207 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96943207 |
| 118 | Lactic acidosis (HP:0003128) | 1.95163614 |
| 119 | T lymphocytopenia (HP:0005403) | 1.94681392 |
| 120 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.94321816 |
| 121 | Entropion (HP:0000621) | 1.90774915 |
| 122 | Pustule (HP:0200039) | 1.90416012 |
| 123 | Neutropenia (HP:0001875) | 1.89760155 |
| 124 | Eosinophilia (HP:0001880) | 1.89727772 |
| 125 | Fatigue (HP:0012378) | 1.89406353 |
| 126 | Beaking of vertebral bodies (HP:0004568) | 1.88947168 |
| 127 | Abnormality of chromosome stability (HP:0003220) | 1.88422726 |
| 128 | Abnormal spermatogenesis (HP:0008669) | 1.87918369 |
| 129 | Neoplasm of the pancreas (HP:0002894) | 1.87031617 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86986583 |
| 131 | Rhabdomyosarcoma (HP:0002859) | 1.86768648 |
| 132 | Arterial thrombosis (HP:0004420) | 1.86140395 |
| 133 | Lymphopenia (HP:0001888) | 1.85484526 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 1.85442825 |
| 135 | Increased hepatocellular lipid droplets (HP:0006565) | 1.85278794 |
| 136 | Angiofibromas (HP:0010615) | 1.85231311 |
| 137 | Adenoma sebaceum (HP:0009720) | 1.85231311 |
| 138 | Bone marrow hypocellularity (HP:0005528) | 1.84855065 |
| 139 | Abnormality of the pons (HP:0007361) | 1.84161859 |
| 140 | Anorexia (HP:0002039) | 1.83733716 |
| 141 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83190787 |
| 142 | Abnormality of glycolysis (HP:0004366) | 1.82635185 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.82635185 |
| 144 | Progressive inability to walk (HP:0002505) | 1.82507124 |
| 145 | Increased IgE level (HP:0003212) | 1.82131565 |
| 146 | Granulocytopenia (HP:0001913) | 1.81620451 |
| 147 | Hypothermia (HP:0002045) | 1.81389675 |
| 148 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80524009 |
| 149 | Pancreatic fibrosis (HP:0100732) | 1.80449530 |
| 150 | Mitochondrial inheritance (HP:0001427) | 1.80164975 |
| 151 | Cerebral hypomyelination (HP:0006808) | 1.79989210 |
| 152 | Abnormality of T cell number (HP:0011839) | 1.79752092 |
| 153 | Abnormality of the preputium (HP:0100587) | 1.79404926 |
| 154 | Verrucae (HP:0200043) | 1.79272096 |
| 155 | Papilloma (HP:0012740) | 1.79272096 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.78674624 |
| 157 | Pulmonary infiltrates (HP:0002113) | 1.78518983 |
| 158 | Abnormality of reticulocytes (HP:0004312) | 1.78507374 |
| 159 | Respiratory difficulties (HP:0002880) | 1.77833760 |
| 160 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77037556 |
| 161 | Hypoplasia of the thymus (HP:0000778) | 1.76923530 |
| 162 | Abnormal biliary tract physiology (HP:0012439) | 1.76677672 |
| 163 | Bile duct proliferation (HP:0001408) | 1.76677672 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.75892937 |
| 165 | Hyperalaninemia (HP:0003348) | 1.75892937 |
| 166 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75892937 |
| 167 | Hemoptysis (HP:0002105) | 1.75736804 |
| 168 | Episodic fever (HP:0001954) | 1.75506693 |
| 169 | Exertional dyspnea (HP:0002875) | 1.75379321 |
| 170 | Squamous cell carcinoma (HP:0002860) | 1.74779326 |
| 171 | Spontaneous hematomas (HP:0007420) | 1.74628121 |
| 172 | Chronic diarrhea (HP:0002028) | 1.74452028 |
| 173 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74334510 |
| 174 | Gangrene (HP:0100758) | 1.74332951 |
| 175 | Constricted visual fields (HP:0001133) | 1.74125548 |
| 176 | Hematochezia (HP:0002573) | 1.73668587 |
| 177 | Gastrointestinal stroma tumor (HP:0100723) | 1.72539229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 4.37974651 |
| 2 | BUB1 | 3.69183200 |
| 3 | EIF2AK1 | 3.65521267 |
| 4 | WEE1 | 3.48293210 |
| 5 | NME2 | 3.47964562 |
| 6 | SIK3 | 3.31615504 |
| 7 | CDC7 | 3.26634682 |
| 8 | TESK2 | 2.52272135 |
| 9 | SCYL2 | 2.46882485 |
| 10 | EIF2AK3 | 2.27015440 |
| 11 | VRK1 | 2.25216539 |
| 12 | STK16 | 2.20772751 |
| 13 | RPS6KA4 | 2.20690943 |
| 14 | MAP4K1 | 2.18302981 |
| 15 | BRSK2 | 2.07087809 |
| 16 | NEK1 | 2.04935532 |
| 17 | EEF2K | 2.01935039 |
| 18 | MST4 | 2.01352010 |
| 19 | ACVR1B | 2.00766020 |
| 20 | BRD4 | 1.99073771 |
| 21 | RIPK4 | 1.99026163 |
| 22 | NEK2 | 1.87499445 |
| 23 | ZAK | 1.83136588 |
| 24 | MAP3K11 | 1.80248445 |
| 25 | PIM2 | 1.78945707 |
| 26 | BCR | 1.78341182 |
| 27 | FES | 1.75120187 |
| 28 | KDR | 1.74794778 |
| 29 | FLT3 | 1.61738809 |
| 30 | LRRK2 | 1.57482411 |
| 31 | FRK | 1.57310958 |
| 32 | RPS6KB2 | 1.53353758 |
| 33 | MAP2K3 | 1.53320126 |
| 34 | ZAP70 | 1.44328096 |
| 35 | PKN2 | 1.43195179 |
| 36 | SRPK1 | 1.42334670 |
| 37 | ERBB3 | 1.39808333 |
| 38 | BMPR2 | 1.36976312 |
| 39 | ITK | 1.34783988 |
| 40 | MAPKAPK3 | 1.34528088 |
| 41 | BRSK1 | 1.32626638 |
| 42 | PLK4 | 1.32139106 |
| 43 | TAOK3 | 1.29256200 |
| 44 | BCKDK | 1.28162215 |
| 45 | NUAK1 | 1.27929382 |
| 46 | PLK1 | 1.23701989 |
| 47 | TSSK6 | 1.21598914 |
| 48 | ATR | 1.19200932 |
| 49 | PAK4 | 1.17584538 |
| 50 | DYRK3 | 1.16250097 |
| 51 | CSK | 1.16026614 |
| 52 | TGFBR1 | 1.15515281 |
| 53 | MAP2K6 | 1.14203891 |
| 54 | CCNB1 | 1.12280309 |
| 55 | TAF1 | 1.10687449 |
| 56 | CDK7 | 1.09311188 |
| 57 | TESK1 | 1.09240805 |
| 58 | MAP3K12 | 1.09069619 |
| 59 | MAP4K2 | 1.08982017 |
| 60 | MAP3K8 | 1.08068981 |
| 61 | AURKB | 1.07468220 |
| 62 | KIT | 1.06975269 |
| 63 | TRIB3 | 1.06450492 |
| 64 | MAP2K7 | 1.02148804 |
| 65 | YES1 | 1.01858271 |
| 66 | TLK1 | 0.99746363 |
| 67 | BTK | 0.99352816 |
| 68 | TXK | 0.97609515 |
| 69 | STK10 | 0.97284593 |
| 70 | PASK | 0.96426138 |
| 71 | MAP3K14 | 0.95476110 |
| 72 | MAP3K4 | 0.94222905 |
| 73 | TYK2 | 0.91204754 |
| 74 | STK38L | 0.89542908 |
| 75 | MAP3K5 | 0.88997978 |
| 76 | MARK3 | 0.88509018 |
| 77 | IKBKB | 0.88306263 |
| 78 | AURKA | 0.87602118 |
| 79 | TTK | 0.87309028 |
| 80 | IRAK1 | 0.86625433 |
| 81 | JAK3 | 0.85625762 |
| 82 | WNK3 | 0.84914959 |
| 83 | KSR1 | 0.84811629 |
| 84 | IRAK4 | 0.84789409 |
| 85 | CDK19 | 0.83386749 |
| 86 | HCK | 0.83087940 |
| 87 | TEC | 0.82860975 |
| 88 | ILK | 0.81430788 |
| 89 | DAPK1 | 0.81372458 |
| 90 | MAP3K3 | 0.79847445 |
| 91 | IRAK2 | 0.79744540 |
| 92 | MAPK13 | 0.79427751 |
| 93 | MKNK2 | 0.79078511 |
| 94 | ERN1 | 0.76619294 |
| 95 | BLK | 0.74857479 |
| 96 | PIM1 | 0.74226608 |
| 97 | JAK2 | 0.74184529 |
| 98 | PRKCQ | 0.72049656 |
| 99 | TBK1 | 0.69900971 |
| 100 | CSF1R | 0.69154557 |
| 101 | DYRK1B | 0.67399364 |
| 102 | PLK3 | 0.67288870 |
| 103 | MKNK1 | 0.67188540 |
| 104 | CAMKK2 | 0.66598179 |
| 105 | PNCK | 0.65645242 |
| 106 | FGR | 0.64537701 |
| 107 | CDK4 | 0.64420454 |
| 108 | NME1 | 0.64346275 |
| 109 | MAP2K4 | 0.64280315 |
| 110 | PINK1 | 0.63237266 |
| 111 | EPHA2 | 0.62560509 |
| 112 | GRK1 | 0.62255641 |
| 113 | SYK | 0.61878926 |
| 114 | BRAF | 0.61783729 |
| 115 | CHEK2 | 0.61522210 |
| 116 | RAF1 | 0.57663283 |
| 117 | PIK3CG | 0.56668522 |
| 118 | STK4 | 0.55963828 |
| 119 | CHEK1 | 0.55848480 |
| 120 | MAP3K10 | 0.55631367 |
| 121 | PRKG2 | 0.55209127 |
| 122 | CSNK2A1 | 0.55145630 |
| 123 | IRAK3 | 0.55134963 |
| 124 | TAOK2 | 0.54977793 |
| 125 | CDK3 | 0.53486269 |
| 126 | PAK1 | 0.52178807 |
| 127 | CSNK2A2 | 0.51092961 |
| 128 | NLK | 0.50017721 |
| 129 | MAP3K6 | 0.48002470 |
| 130 | OXSR1 | 0.47090878 |
| 131 | MAPK7 | 0.43228119 |
| 132 | LYN | 0.43050184 |
| 133 | DYRK1A | 0.42466480 |
| 134 | CSNK1G1 | 0.42231822 |
| 135 | ARAF | 0.41422400 |
| 136 | AKT3 | 0.41320752 |
| 137 | CDK9 | 0.40737208 |
| 138 | GRK6 | 0.39746564 |
| 139 | TNK2 | 0.39742778 |
| 140 | JAK1 | 0.39704738 |
| 141 | EIF2AK2 | 0.39671339 |
| 142 | CSNK1G2 | 0.39552503 |
| 143 | MATK | 0.39301039 |
| 144 | MAP3K2 | 0.38473925 |
| 145 | CDK2 | 0.38211175 |
| 146 | MUSK | 0.37952374 |
| 147 | MYLK | 0.37916192 |
| 148 | STK24 | 0.37832339 |
| 149 | RPS6KA5 | 0.37681044 |
| 150 | LCK | 0.37468143 |
| 151 | ATM | 0.37151626 |
| 152 | IKBKE | 0.34482973 |
| 153 | CDK6 | 0.33083550 |
| 154 | TAOK1 | 0.31930504 |
| 155 | CHUK | 0.31866286 |
| 156 | ABL2 | 0.31579560 |
| 157 | MAPK11 | 0.30448844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.85430393 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.33204248 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.98332602 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.77413466 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.20746613 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.14509780 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.03221166 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.91024663 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.86082090 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79802160 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.64507973 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.63857842 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.54971456 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.52137371 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42527896 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.41659997 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.21791266 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.10819358 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 2.01448155 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.82942228 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71028089 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68233872 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66529927 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55975808 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54078412 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46170898 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.44060430 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38508648 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.35362920 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.35038230 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33256897 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31834486 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30394199 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29826274 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.29663509 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27604623 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26493074 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.21929104 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16046473 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14328933 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12794998 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10967563 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04630108 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01144608 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00750693 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98862131 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98833046 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96967026 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95843922 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95106448 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87176336 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83348294 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80745080 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79845255 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.76984554 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76431572 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75968129 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.75252773 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74543838 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74055276 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.73307689 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70125642 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.68235988 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67069664 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66592006 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65152711 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64534805 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64254879 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64028175 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63913981 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63659310 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62985673 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62936587 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61461844 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.61353844 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.61181945 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61054854 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60007730 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58753135 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58379131 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54683028 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53751463 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.53354229 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53077020 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51452884 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49514033 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.49191050 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49177039 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46982017 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46583863 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45118959 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44248288 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.43389760 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.42893676 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41613967 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41246349 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39114965 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38457225 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38167588 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37674334 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37038175 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36362450 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.35282882 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35262483 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34351770 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33245728 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.32946031 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30795654 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30661801 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30174898 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30136524 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29685824 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29057362 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.28530286 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27581489 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26889177 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26712149 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26612188 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26464201 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.25693457 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25339474 |
| 122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25032665 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24551524 |
| 124 | Allograft rejection_Homo sapiens_hsa05330 | 0.24469172 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23726056 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20857139 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20107652 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19015202 |
| 129 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17987449 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17355301 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16781098 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.16735086 |
| 133 | Tuberculosis_Homo sapiens_hsa05152 | 0.16071680 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15234638 |

